First Amendment Working Group attorney, Chris Hansen
, talks about this week’s New York federal court ruling
that declared patents on genes associated with hereditary breast and ovarian cancer invalid. And Nathan Tinker
, executive director of the New York Biotechnology Association
, explores the ruling's potential impact on the biotech industry.